Arteriosclerosis obliterans. Diagnostic and nonoperative treatment options.
Ku A, Nagler W.
Postgrad Med. 1995 Nov;98(5):203-4, 207-10, 212.
[Peripheral arteriosclerosis obliterans].
Langer B.
Rev Paul Med. 1990 Sep-Oct;108(5):195-9.
[Arteriosclerosis obliterans (ASO)].
Koshikawa M, Ikeda U.
Nihon Rinsho. 2010 May;68(5):926-9.
Arteriosclerosis obliterans.
DEDICHEN J.
Bibl Cardiol. 1958;8:55-8.
[Arteriosclerosis obliterans(ASO) in diabetic patients].
Tanaka Y.
Nihon Rinsho. 2003 Jul;61(7):1187-93.
Arteriosclerosis obliterans of the lower limbs as a model of peripheral vascular disease with hypertension.
Safar ME.
J Cardiovasc Pharmacol. 1991;18 Suppl 4:S73-7.
Functional interaction between immune checkpoints and lipid metabolism in the development of arteriosclerosis obliterans.
Zhang J, Cui L, Meng X, Luo Y, Ou J, Wang S, Qiu M.
Front Immunol. 2025 Sep 1;16:1665454. doi: 10.3389/fimmu.2025.1665454. eCollection 2025.
Problems of aging: diagnosing and treating leg pain due to arteriosclerosis obliterans.
Moylan JA.
Postgrad Med. 1975 Oct;58(4):135-41. doi: 10.1080/00325481.1975.11714175.
[Arteriosclerosis obliterans of the aorta and lower limbs. Aneurysm].
Emmerich J, Bura A.
Rev Prat. 2006 Jan 31;56(2):207-12.
Arteriosclerosis obliterans in Japanese diabetic patients.
Matsuda A, Kuzuya T.
Tohoku J Exp Med. 1983 Dec;141 Suppl:569-73. doi: 10.1620/tjem.141.suppl_569.
